RESUMO
OBJECTIVE: The pilot study aimed to apply and evaluate the German version of DIALOG+ in patients with psychosis. METHODS: The German version of DIALOG+ was used with ten patients with psychosis in five sessions each over a 8-week period. DIALOG+ is a brief intervention that is supported by an App, structures clinical routine consultations and helps patients to define and achieve personal goals. For evaluating outcomes, symptom levels, disability and subjective quality of life before and after treatment were compared. RESULTS: Adherence was high with a total of 49 of 50 planned sessions completed. Patients showed significant improvements in schizophrenia symptoms (dâ=â0.88), depressive symptoms (dâ=â0.85), everyday impairment (dâ=â0.83) and subjective quality of life (dâ=â0.12). CONCLUSION: The German version of DIALOG+ provides a feasible and promising approach to make routine meetings therapeutically effective.
Assuntos
Transtornos Psicóticos , Esquizofrenia , Alemanha , Humanos , Projetos Piloto , Transtornos Psicóticos/diagnóstico , Qualidade de Vida , Esquizofrenia/diagnósticoRESUMO
OBJECTIVE: This study investigated the feasibility of a novel blended (face-to-face and computer-based) group intervention for the reduction of depressive symptoms in major depression. DESIGN: Patient-centred uncontrolled interventional study. SETTING: University setting in a general community sample. A multimodal recruitment strategy (public health centres and public areas) was applied. PARTICIPANTS: Based on independent interviews, 26 participants, diagnosed with major depressive disorder (81% female; 23% comorbidity >1 and 23% comorbidity >2), entered treatment. INTERVENTION: Acceptance and mindfulness based, as well as self-management and resource-oriented psychotherapy principles served as the theoretical basis for the low-threshold intervention. The blended format included face-to-face sessions, complemented with multimedia presentations and a platform featuring videos, online work sheets, an unguided group chat and remote therapist-patient communication. MAIN OUTCOME MEASURES: The Center for Epidemiological Studies-Depression scale and the 12-item General Health Questionnaire. RESULTS: Large to very large within group effect sizes were found on self-reported depression (F(2, 46.37)=25.69, p<0.001; d=1.80), general health (F(2,46.73)=11.47, p<0.001; d=1.32), personal resources (F(2,43.36)=21.17, p<0.001; d=0.90) and mindfulness (F(2,46.22)=9.40, p<0.001; d=1.12) after a follow-up period of 3 months. Treatment satisfaction was high, and 69% ranked computer and multimedia use as a therapeutic factor. Furthermore, participants described treatment intensification as important advantage of the blended format. Half of the patients (48%) would have preferred more time for personal exchange. CONCLUSION: The investigated blended group format seems feasible for the reduction of depressive symptoms in major depression. The development of blended interventions can benefit from assuring that highly structured treatments actually meet patients' needs. As a next step, the intervention should be tested in comparative trials in routine care. TRIAL REGISTRATION NUMBER: DRKS00010894; Pre-results.